Word: welles
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...Well, under Stalin...
...bother to label Mamet a liberal or a conservative. He is a free radical attaching himself to whatever particle of reality promises further knowledge of the whole. At times he can be -- well, freakish. How about an interpretation of Superman as the most vulnerable of beings because his childhood had been destroyed? Outre? You bet. But as Mamet confesses, "I've always been more comfortable sinking while clutching a good theory than swimming with an ugly fact." R.Z.S...
...lies ahead. Louis-Dreyfus has his work cut out for him -- and a compensation package geared to inspire success. On top of a reported salary of $785,000, Louis-Dreyfus will control stock options worth at least $3 million. That value will rise substantially if he does his job well. Earlier this month, Louis-Dreyfus pledged to boost the value of the company's shares, which have traded as high as $10.70, from their current price of $4 to at least $7.85 within three years. More than another increase in its global reach, that is the kind of growth figure...
...dogs are well protected too. Bred by Steger, they are hybrids of Siberian husky, malamute and timber wolf. They are fed a high-protein diet and are outfitted with jackets and booties. Even so, the journey has been brutal for the animals. Fifteen of them became so exhausted that they had to be airlifted out temporarily to Patriot Hills. One of Steger's favorites, an eight-year-old named Tim who had gone with him to the North Pole, died during the blizzard...
...result, the agency has a bad case of bureaucratic burnout. Approval of new drugs requires mountains of corporate filings, and delays in processing applications now run well over two years. That has led to more scandal: this summer investigators discovered that a few generic-drug developers had bribed underpaid FDA employees to speed up the agency's responses to the paperwork for their products. Three FDA reviewers have already pleaded guilty, and more prosecutions are expected. "This past year has been one of the most difficult in FDA's history," said Commissioner Frank Young last week...